Oct 2, 2026 09:00AM
Aug 10, 2026 04:05PM
Jun 2, 2026 08:02AM
Jun 2, 2026 08:00AM
May 15, 2026 11:45AM
Mar 25, 2026 04:01PM
Mar 25, 2026 04:01PM ProKidney Expands Senior Leadership Team with Appointment of Greg Madison as Chief Commercial Officer
Mar 18, 2026 04:00PM
Nov 10, 2025 04:15PM
Nov 6, 2025 11:00AM
Nov 6, 2025 11:00AM
Aug 12, 2025 04:01PM
Jul 15, 2025 07:30AM
Jul 15, 2025 07:30AM ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel
Jul 8, 2025 07:00AM
Jul 8, 2025 07:00AM
Jul 1, 2025 12:44PM
Jul 1, 2025 12:43PM
May 12, 2025 04:15PM
Mar 17, 2025 07:30AM
Nov 12, 2024 07:30AM ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting
Sep 3, 2024 07:31AM
Sep 3, 2024 07:30AM
Aug 9, 2024 07:00AM
Jun 10, 2024 06:30AM
Jun 10, 2024 05:30AM
May 21, 2024 07:00AM
May 10, 2024 07:00AM ProKidney Reports Business Updates and First Quarter 2024 Financial Results
Mar 25, 2024 06:06AM
Mar 25, 2024 06:05AM
Mar 21, 2024 07:49PM
Nov 30, 2023 06:05AM
Nov 21, 2023 06:05AM
Nov 14, 2023 06:05AM
Nov 13, 2023 05:02PM ProKidney (PROK) Reports Positive Interim Data from RMCL-002 Phase 2 Clinical Trial of Renal Autologous Cell Therapy
Nov 13, 2023 05:02PM
Oct 30, 2023 04:12PM
Sep 5, 2023 06:05AM
Aug 10, 2023 04:10PM
Jul 18, 2023 06:05AM
Jul 17, 2023 06:05AM
Jun 13, 2023 12:05PM ProKidney Announces Purchase of Manufacturing Facility in Greensboro, NC
Jun 1, 2023 04:05PM
May 11, 2023 04:01PM
May 4, 2023 06:05AM
Mar 28, 2023 04:12PM
Mar 28, 2023 04:12PM
Mar 3, 2023 06:05AM
Jan 10, 2023 04:06PM ProKidney Corp (PROK) Announces Publication of Trial Design for Phase 2 Multicenter Clinical Trial of REACT
Jan 10, 2023 04:05PM

1,199,250 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All